[1] Ctr Genom & Oncol Res Pfizer Univ Granada Andalusi, Otol & Neurotol Grp CTS 495, Dept Genom Med, GENYO,PTS Granada, Granada, Spain
[2] Univ Granada, Div Otolaryngol, Dept Surg, Inst Invest Biosanitaria,Ibs GRANADA, Granada, Spain
[3] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Sensorineural Pathol Programme, Madrid, Spain
[4] Ctr Genom & Oncol Res Pfizer Univ Granada Andalusi, Genet Complex Dis Grp, Dept Genom Med, GENYO, Granada, Spain
[5] Hosp Univ Salamanca, Dept Otolaryngol, Inst Invest Biome Salamanca IBSAL, Salamanca, Spain
[6] Univ Salamanca, Dept Surg, Div Otolaryngol, Salamanca, Spain
[7] Hosp Can Misses, Dept Otolaryngol, Ibiza, Spain
[8] Complexo Hosp Univ, Dept Otorhinolaryngol, Div Otoneurol, Santiago De Compostela, Spain
[9] Univ Santiago De Compostela, Dept Surg & Med Surg Special, Santiago De Compostela, Spain
[10] Univ Sydney, Kolling Inst, Fac Med & Hlth, Sch Med Sci,Menieres Dis Neurosci Res Program, Sydney, NSW, Australia
[11] PTS Granada, Otol & Neurotol Grp CTS495, GENYO, Ave Ilustrac 114, Granada 18016, Spain